Advertisement

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Deborah A. Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok, Ashley Cass, Nicole M. Haynes, Kathryn Kinross, Hideo Yagita, Richard C. Koya, Thomas G. Graeber, Antoni Ribas, Grant A. McArthur, and Mark J. Smyth

Find articles by Knight, D. in: JCI | PubMed | Google Scholar

Find articles by Ngiow, S. in: JCI | PubMed | Google Scholar

Find articles by Li, M. in: JCI | PubMed | Google Scholar

Find articles by Parmenter, T. in: JCI | PubMed | Google Scholar

Find articles by Mok, S. in: JCI | PubMed | Google Scholar

Find articles by Cass, A. in: JCI | PubMed | Google Scholar

Find articles by Haynes, N. in: JCI | PubMed | Google Scholar

Find articles by Kinross, K. in: JCI | PubMed | Google Scholar

Find articles by Yagita, H. in: JCI | PubMed | Google Scholar

Find articles by Koya, R. in: JCI | PubMed | Google Scholar

Find articles by Graeber, T. in: JCI | PubMed | Google Scholar

Find articles by Ribas, A. in: JCI | PubMed | Google Scholar

Find articles by McArthur, G. in: JCI | PubMed | Google Scholar

Find articles by Smyth, M. in: JCI | PubMed | Google Scholar

First published July 1, 2013 - More info

Published in Volume 123, Issue 7 (July 1, 2013)
J Clin Invest. 2013;123(7):3182–3182. doi:10.1172/JCI70645.
Copyright © 2013, The American Society for Clinical Investigation.
Published July 1, 2013

Erratum

Original citation: J. Clin. Invest. 2013;123(3):1371–1381. doi:10.1172/JCI66236.

Citation for this erratum: J. Clin. Invest. 2013;123(7):3182. doi:10.1172/JCI70645.

During preparation of the manuscript, Figure 9 was labeled incorrectly. The correct figure is below.

Figure 9

The JCI regrets the error.

Revision history
  • Version 1 (February 23, 2015): No description
Advertisement
Advertisement